MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes

MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes

The majority of lung cancer patients are diagnosed with metastatic disease. This study identified a set of 73 microRNAs (miRNAs) that classified lung cancer tumors from normal lung tissues with an overall accuracy of 96.3% in the training patient cohort (<i>n</i> = 109) and 91.7% in unsu...

Full description

Bibliographic Details
Main Authors: Qing Ye, Rebecca Raese, Dajie Luo, Shu Cao, Ying-Wooi Wan, Yong Qian, Nancy Lan Guo
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
lung cancer
diagnosis
prognosis
CRISPR-Cas9/RNAi
radiotherapy response
drug response
Online Access:https://www.mdpi.com/2072-6694/15/8/2294

Internet

https://www.mdpi.com/2072-6694/15/8/2294

Similar Items